Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The importance of vaccinated individuals to population-level evolution of pathogens

View ORCID ProfileMaria A. Gutierrez, View ORCID ProfileJulia R. Gog
doi: https://doi.org/10.1101/2022.11.29.22282822
Maria A. Gutierrez
1Department of Applied Mathematics and Theoretical Physics, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria A. Gutierrez
  • For correspondence: mag84{at}cam.ac.uk
Julia R. Gog
1Department of Applied Mathematics and Theoretical Physics, University of Cambridge
2JUNIPER – Joint UNIversities Pandemic and Epidemiological Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia R. Gog
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Virus evolution shapes the epidemiological patterns of infectious disease, particularly via evasion of population immunity. At the individual level, host immunity itself may drive viral evolution towards antigenic escape. Using compartmental SIR-style models with imperfect vaccination, we allow for the probability of immune escape to differ in vaccinated and unvaccinated hosts. As the relative contribution to selection in these different hosts varies, the overall effect of vaccination on the antigenic escape pressure at the population level changes.

We find that this relative contribution to escape is important for understanding the effects of vaccination on the escape pressure and we draw out some fairly general patterns. If vaccinated hosts do not contribute much more than unvaccinated hosts to the escape pressure, then increasing vaccination always reduces the overall escape pressure. In contrast, if vaccinated hosts contribute significantly more than unvaccinated hosts to the population level escape pressure, then the escape pressure is maximised for intermediate vaccination levels.

We also find that these results depend on the vaccine efficacy against transmission, particularly through the partial protection against infection. This work highlights the potential value of understanding better how the contribution to antigenic escape pressure depends on individual host immunity.

1 Introduction

Vaccines against infectious pathogens reduce incidence and deaths, although there is a risk that they could favour new antigenic variants [1]. For example, since population immunity against circulating SARS-CoV-2 variants controls virus spread [2], the long-term dynamics of the COVID-19 pandemic depend on the evolutionary trajectory of the virus [1]. Here we investigate how vaccination changes the appearance probability of strains capable of evading host immunity, relative to the baseline of no vaccination. Antigenic escape is complex, with strains generated and selected on various scales [3]. We focus exclusively on the generation of escape strains [4], [5], rather than on their establishment after they first appear[6], [7]. Our work builds on other mathematical studies of COVID-19 immune escape risk [4], [5], [8]. We pay particular attention to selection in vaccinated hosts, relative to the unvaccinated.

Evolution of antigenic traits in SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) [9] generates new variants [10]. Some of these variants (B.1.1.7, alpha; B.617.2, delta) appear to have a transmission advantage over their precursors [11]. B.1.1.529 —omicron—significantly escapes existing immunity [12], but variants with immune escape, at least to some extent, date back to 2020, before the roll-out of vaccines (B.1351, beta; B.617.2, delta) [11]. Therefore it is important to understand how vaccination impacts antigenic drift. Vaccines may affect the evolution of other pathogen traits, such as virulence [13], but we focus on immune escape.

To the best of our knowledge, there is not yet evidence to assess how COVID-19 vaccines impact virus genomic diversity in an individual host [14]. Some COVID-19 models assume that escape occurs only or primarily in hosts with previous immunity [4], [5]. On the contrary, others assume that vaccination entirely prevents infection [8], and thus escape can only occur in unvaccinated hosts.

Models for pathogens other than SARS-CoV-2 often assume that viruses mutate at the same rate in all hosts [7], [15], [16], [17]. However, in human Influenza A, host immunity can select for antigenic mutations [18]. This effect may be important [19] for more ambitious vaccination campaigns, such as a universal influenza vaccine [20].

Given that we do not generally know the relative selective pressures exerted by infections in vaccinated hosts compared to the unvaccinated, we explore a range of values for this contribution to escape. We define a parameter (Section 2.1) that measures this relative contribution to escape. We use this parameter to express the escape pressure in terms of the infections in vaccinated and unvaccinated hosts, as in (1). We then combine this with deterministic compartmental models for vaccination (Section 2.2) that provides lifelong imperfect immunity. We explore two scenarios: a single wave and endemic disease. We calculate the resultant escape pressure in each of these contexts and describe how it changes as the vaccination coverage varies (Section 2.3). We find the trade-off between selection and the vaccine efficacies (VEs) in the escape pressure of a fully-vaccinated population and the vaccination coverage that maximises the escape pressure (Section 3).

We find that the relative selection strength from infections in vaccinated and unvaccinated hosts shapes the escape pressure. In particular, we find two different qualitative behaviours for how the escape pressure depends on the vaccination coverage. These two behaviours are separated by a threshold value of this relative contribution to escape, in which vaccinated hosts contribute individually somewhat more to escape than the unvaccinated. If the relative contribution to escape is below this threshold, vaccination always reduces antigenic escape, as in [15]. However, above this threshold, intermediate vaccination levels are the most likely to generate escape strains, as in [4]. We also find that the susceptibility reduction provided by the vaccines has a large effect on the escape pressure. The reduction in infectiousness is less important, but still lowers escape by reducing prevalence.

2 Methods

2.1 Measure of escape pressure

We take a simple approach building on [4] to study the generation of strains at the population-level. We assume that the escape pressure P depends linearly on the number of cases, as Embedded Image Underlying this factor is the assumption that each infection contributes very slightly to escape potential. We weight the (breakthrough) infections in vaccinated hosts NV, relative to the infections in naïve hosts NU, by a factor θE. Only the relative value of P is important (see Section 2.3), so we only need the relative weighting θE amongst infection in the vaccinated and unvaccinated rather than their absolute contribute to escape. θE is comparable to the vaccine efficacies θ* of [4] (see Section 2.2), in that it is a factor that reflects a change in a single host induced by vaccination. For example, if θE > 1, vaccinated hosts infected with the resident strain would be more likely to pass on escape strains than the unvaccinated. Lower viral loads and shorter infections in the vaccinated [21] could lead to fewer mutations [22]. But in the vaccinated, these escape strains can avoid the vaccine-induced immunity that the original strain faces [23], and may be selected within a host enough to be transmitted to others [22]. There is no prior reason to exclude any value θE ≥ 0, so we explore the full range.

2.2 Epidemic models

We use systems of ordinary differential equations (ODEs) to generate NU and NV under various scenarios. We assume that the population is well-mixed and a single-strain infectious disease circulates unaffected by any escape strain it may have generated. We consider two epidemiological scenarios. In scenario (a) the outbreak is transient, which can be interpreted as a single epidemic wave. In scenario (b) the system is modified so that it reaches a non-zero equilibrium, corresponding to endemic disease.

We separate individuals by vaccination status and assume that vaccine immunity does not wane. We scale time so that the recovery rate is 1. In our models, the vaccines are not assumed to be perfect: vaccinated individuals can become infected, albeit at a lower rate, contributing to the escape pressure. We split the (imperfect) transmission blocking from vaccines into two components, θS and θI, as defined in [4]. θS is the susceptibility reduction (VE against infection): θS = 0 corresponds to perfect protection, while θS = 1 corresponds to no protection. Similarly, θI is the infectivity reduction (VE against transmission), if an infection occurs. For mathematical convenience, the reduction in susceptibility from vaccination is polarised [16]: some vaccinated individuals are entirely immune to the infection, while the rest are as susceptible as the unvaccinated. Appendix A.2 shows that the same qualitative results hold with an alternative formulation for immunity.

In both scenarios, SU and SV are the vaccinated and unvaccinated proportions of the population susceptible to the disease; IU and IV, the vaccinated or unvaccinated proportions that are infected; RU and RV, the vaccinated or unvaccinated recovered proportions. R0 is the basic reproduction number and c is the proportion of the population who are vaccinated.

Scenario (a): transient epidemic

In the transient scenario, recovered hosts have full permanent immunity and the system is Embedded Image Embedded Image Embedded Image with λ(t) = IU + θIIV. The initial conditions are SU = 1 − c, SV = cθS, RU = 0 = RV, and an infinitesimal number of infected individuals. The remaining c(1 − θS) proportion of the population has full immunity from vaccination, so they do not appear in the compartments of the system. Appendix A.1 shows that for polarised vaccine immunity —and non-assortiative mixing as here—, the original proportion between vaccinated and unvaccinated susceptibles is maintained and extended to the other compartments: Embedded Image This relation (5) reduces the system to: Embedded Image Embedded Image where ϵ accounts for the initial cases. (6)-(7) describe a standard SIR model, up to rescaling the effective reproduction number and the population size. The initial effective reproduction number is Re = R0[1 − c + cθSθI]. If the vaccination coverage is above Embedded Image, herd immunity prevents an outbreak and prevalence decreases exponentially. From (6)-(7), if Embedded Image, the cumulative infections in unvaccinated are Embedded Image, where is the Lambert-W function [24] (see Appendix A.1). The breakthrough infections are Embedded Image. Thus, the escape pressure (1) is Embedded Image

Scenario (b): endemic disease

To achieve an endemic scenario, we consider two possible extensions of the SIR model (2)-(4) that replace susceptibles. If starting from the same initial conditions as in the transient scenario, these extensions reach an endemic state if Re > 1. In both cases, we find the proportions Embedded Image of infected individuals at the endemic equilibrium and use them to evaluate the escape pressure Pb at endemicity. Both models lead the same expression Pb for the resulting escape pressure, up to a constant of proportionality: Embedded Image In the first extension, we assume that immunity from infections wanes at a constant rate ω, instead of being permanent. We still assume that vaccine immunity is lifelong. The modified ODEs are Embedded Image Embedded Image Embedded Image with λ as before. We use (5), which still holds (see Appendix A.1), to find the endemic state (setting to zero the time-derivatives). For Re > 1, there is an equilibrium state with Embedded Image. Hence, for Re > 1, the escape pressure rate at the endemic equilibrium is Embedded Image.

In the second extension, we include births and deaths, at the same homogeneous per capita rate μ, so that the population size is conserved. A proportion c of the population is vaccinated at birth. We assume that neither infection nor immunity are maternally transmitted. Therefore, the births appear in Embedded Image and Embedded Image as μ(1 − c) and μcθS. The number of individuals V with full vaccine immunity obeys Embedded Image with V (0) = c(1 − θS), so V (t) = c(1 − θS) at all times. The new ODEs are Embedded Image Embedded Image Embedded Image with λ as before. Condition (5) still holds (see Appendix A.1). For Re > 1 + μ, there is an endemic state Embedded Image. Hence Embedded Image. For μ ≪ 1, which corresponds to an infectious period much shorter than the host’s life expectancy, Pb = μ(1 − c(1 − θEθS)) [1 − Re−1] to leading order in μ.

2.3 Output metric

To study the escape pressure as a function of the vaccination coverage, we normalise the expressions (8) and (9) by their value at c = 0 (in the absence of vaccination): Embedded Image Embedded Image If Embedded Image, the vaccination coverage c increases the escape pressure from no vaccination.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1:

Pameters and functions from our models that appear in the results section.

3 Results

First, we focus on the effects of θE on the escape pressure in a fully vaccinated population. We vary θS, θI and θE, and fix the vaccination coverage at c = 1. If vaccination does not prevent the epidemic, i.e., R0θSθI < 1: Embedded Image and Embedded Image for R0θSθI ≥ 1. Both expressions in (18) depend only on R0, θSθI and θSθE, but this dependence changes for “leaky” immunity (see Appendix A.2). Figures 1a, S1a show how the escape pressure in a fully vaccinated population Embedded Image depends on the vaccine parameters θS, θI and θE. As expected, it is unchanged relative to no vaccination Embedded Image when θE = 1 = θS = θI, because then vaccines have no effect in our model. For a fixed VE, the escape pressure increases with θSθE, because escape becomes more likely in the vaccinated. Similarly, for fixed θSθE, the escape pressure decreases as the vaccines become more effective, because fewer infections reduce the opportunities for escape mutations. Therefore, the escape pressure in a fully-vaccinated population is less than in an unvaccinated population Embedded Image if the population is close enough to herd-immunity. As a consequence, θSθE < 1 is not necessary for Embedded Image. It is sufficient, because if θEθS < 1, vaccination blocks the expected escape so Embedded Image unsurprisingly. Our results shows that vaccines can reduce the total escape pressure even if θSθE > 1.

Figure 1:
  • Download figure
  • Open in new tab
Figure 1:

(a): Escape pressure Embedded Image in a fully vaccinated population relative to an unvaccinated population. White dotted curve Embedded Image: vaccine parameters that give the same escape as in an unvaccinated population. White dashed line: VE that prevents an epidemic in a fully vaccinated population (the horizontal axis is scaled to above this value). R0 = 1.4. (b): Escape pressure Embedded Image for variable vaccination coverage c and relative contribution to escape θE from the vaccinated, relative to an unvaccinated population. White solid curve: the vaccination coverage, cm, at which the escape pressure peaks, as a function of θE. White dotted curve Embedded Image: combination of c and θE that give the same escape in a population as in an unvaccinated population. Dashed line: vaccination coverage for herd-immunity threshold (the horizontal axis only shows values of c below this). θS, θI = 0.6, R0 = 1.4.

Next, we consider how the escape pressure changes with a variable vaccination coverage c, and how this is affected by θE. We keep θS and θI fixed for simplicity. Figures 1b, S1b show the escape pressure Embedded Image as a function of c and θE, for fixed VEs. Intuitively, the escape pressure decreases to zero as the vaccination coverage approachesEmbedded Image, the herd immunity threshold (Embedded Image here). When vaccination is slightly below Embedded Image, the outbreak is small (a few infections are enough to build herd immunity) so there are fewer opportunities for escape. It is helpful to consider the vaccination coverage that maximises the escape pressure, which we call cm, as it depends on θE. If θE is below a threshold Embedded Image, then cm = 0. The escape pressure simply decreases with c, because reducing cases outweighs the escape pressure from breakthrough cases. If Embedded Image, then cm > 0. Breakthrough infections can drive evolution and reducing cases may not suffice to reduce the escape pressure, which has a unimodal shape. We can characterise these results analytically. Here we refer to the endemic scenario (Appendix A.1 discusses the transient scenario). Since Pb(c) is concave (d2Pb/dc2 < 0), by (17), the condition for a peak of the escape pressure at a non-zero vaccination level (cm > 0) is Embedded Image Figure S5 plots Embedded Image, as given by (19). Interpreting 1 − θSθI as the transmission-blocking and θEθS − 1 as the escape boost provided by the vaccines, the condition (19) can be rewritten as (escape boost)×(R0 − 1) >(transmission-blocking). If (19) is satisfied, we solve dPb/dc = 0 folr the maximiser of the escape pressure Embedded Image. As expected, cm continuously increases with θE from zero (at Embedded Image). In the limit (θE → ∞ only breakthrough infections contribute to Pb, the analytical expression for cm tends to Embedded Image. This number Embedded Image can be obtained directly as the vaccination coverage that maximises the total number of infections in vaccinated hosts. If herd-immunity from vaccination alone is not possible Embedded Image, Figure S6 shows that a fully vaccinated population (c = 1) can have the largest escape pressure. However, this does not happen Embedded Image if and only if Embedded Image, which holds if the threshold coverage for Re < 1 is less than one Embedded Image, because then R0θSθI < 1 < R0. Therefore, unsurprisingly, the escape pressure cannot peak at c = 1 if Embedded Image (since c = 1 prevents the epidemic).

Finally, we study how each of θS, θI affects the escape pressure as the vaccination coverage varies. When infections in the vaccinated drive selection (θE is large), θS contributes more to the escape pressure than θI. Both reduce the total number of cases at the same rate, through Re = R0(1 − c(1 − θSθI)). Additionally, θS (partially) protects the vaccinated from infections, so it lowers the proportion of the total cases in the vaccinated. Hence, if θE > 1, a vaccine that reduces susceptibility has a quantitatively stronger effect on the escape pressure than a vaccine that reduces infectivity. Figures 2, S2, S3, S4 demonstrate that the escape pressure is more sensitive to θS than θI. In particular, Figures 2, S2 show that a sufficiently low θS can lead to the escape pressure peaking at no vaccination (cm = 0), while for the same background parameter values the escape pressure peaks at intermediate vaccination levels (cm > 0), regardless of θI. We can define thresholds values Embedded Image similar to Embedded Image (see Figure 1b, S5), such that Embedded Image is the condition for the escape pressure to peak at no vaccination (cm = 0). Figures 2a, S2a, S3a all have Embedded Image, while Embedded Image only appears in Figure S3b. In the endemic scenario, (19) gives Embedded Image and Embedded Image. Therefore, as in Figure 2b, Embedded Image can be negative which means that the escape pressure peaks at intermediate levels even if the vaccines fully block transmission (θI = 0). Vaccinated hosts are still able to generate escape strains, even if they are not able to transmit the original strain. On the contrary, Embedded Image is always positive, so if vaccines fully prevent infection (θS = 0), vaccination always reduces the escape pressure (cm = 0).

Figure 2:
  • Download figure
  • Open in new tab
Figure 2:

Relative escape pressure Embedded Image at fixed R0 = 1.4 and a high relative contribution to escape from the vaccinated, θE = 10. (a) has fixed θI = 0.6 and the susceptibility VE θS varies. (b) has fixed θI = 0.6 and the infectiousness VE θI varies. On both (a) and (b), the white solid curves mark the vaccination coverage, cm, at which the escape pressure peaks; the dashed lines give the herd-immunity threshold. Considered together, (a) and (b) show that there is more variation in the relative escape pressure if θS varies and θI is fixed.

4 Discussion

4.1 Summary of findings

Introducing a new parameter, θE, we have explored the effect of the contribution to immune escape of cases in vaccinated hosts, relative to the unvaccinated. Taking a parsimonious modelling approach we have studied how the population escape pressure depends on the vaccination coverage, the vaccine efficacies and θE. We have found that θE is critical to determine how the escape pressure depends on the vaccination coverage. If θE is low, escape decreases with vaccination. As θE increases, so that vaccinated hosts contribute relatively more to escape, escape is largest at intermediate vaccination levels. Therefore, our results show that models of immune escape should take into account the relative contribution to escape of cases in hosts with imperfect immunity. Our results also show mathematically that vaccines which are effective in reducing transmission can generally reduce the population escape pressure, even if they favour escape strains in individual hosts.

4.2 Implications for modelling evolution with imperfect immunity

Our results highlight not only the importance of θE itself, but also the role in reducing escape of θS, the susceptibility vaccine efficacy (VE), especially when vaccinated hosts contribute relatively more to escape (θE > 1). Our results show mathematically the need to consider separately the VEs against infection (susceptibility) and onwards transmission (infectiousness). A purely epidemic model which does not consider immune-induced escape only needs the overall transmission-blocking VE [4]. However, our escape pressure is more sensitive to a reduction in susceptibility than infectivity. The suceptibility VE not only reduces infections but specifically protects the vaccinated, who may exert more selection pressure. Traditional models assume that partial immunity confers only reduced susceptibility or infectivity [16]. Often the dynamics are qualitatively the same [25], so the choice of VE is usually based on tractability [16]. Our work suggests that evolutionary models should split infections by immune status, so that θE can be used, and consider the susceptibility VE separately from the transmisibility VE, so that θS and θE can regulate together the escape pressure. These points may also apply in multi-strain models where partial cross-immunity drives evolution [16]. Furthermore, the contribution to escape of an infected host may change with different vaccine types or number of doses, so along different VEs, different θEs may be needed. Parameters akin to θE could also be appropriate for other phylodynamic models.

4.3 Relation to existing results

As in previous work [8], [3], in our models intermediate vaccination levels could lead to the largest selection pressure for antigenic escape. The same conclusion holds for a wide range of θS and θI values [4] when dividing the population in two subgroups with different contact rates. This population-level result is analogous [4] to the within-host phylodynamic trade-off between viral load and selection pressure [22]. Our works shows that a population-level trade-off can appear without mixing heterogeneity, stochasticity, or detailed within-host dynamics. Past work implicitly uses fixed choices of θE or the VEs (or both). We instead specify the region of (θE, θS, θI) parameter space in which intermediate vaccination levels maximise the escape pressure. Beyond this region, vaccination reduces the escape pressure, as in [15].

4.4 Limitations and further work

Due to the simplicity of our approach, many epidemiological and evolutionary processes could modify our results. We assume that there are no changing mitigation measures, behavioural changes or seasonality effects. Vaccination comes through a single dose of a unique vaccine, administered before the outbreak or at birth. Further work could consider ongoing vaccination, as in [8]. We also neglect the waning of vaccine immunity and assume complete immunity after infection. Infections in individuals with partial or waned immunity may contribute with a different weight to the escape pressure [5]. Heterogeneity in mixing, susceptibility and transmissibility could all play a role in evolution. It may be best to vaccinate first those with more contacts [4], or immunocompromised hosts, who might contribute significantly more to the escape pressure [26]. Moreover, unlike in COVID-19 [21], both scenarios explained here assume that vaccination does not change the recovery rate and that the disease is not fatal. Disease-induced mortality, different infectious periods and hospitalisations would break the proportionality (5), since these effects would be larger in the unvaccinated. Similarly, lifting the well-mixing assumption and including any age or spatial structure could change these patterns. Our work ignores the invasion dynamics of escape strains [6], but simply focuses on the pressure to generate one. An escape strain might be unable to grow if few individuals remain susceptible. In the transient scenario, this could occur if a strains appears late in the epidemic; in the endemic scenario, if the invasion fitness of the escape strain is not large enough for it to replace or coexist with the resident strain. Similarly, stochasticity could drive escape strains extinct shortly after their generation. For example, [8] finds that escape strains appearing in lockdowns are unlikely to survive stochastic extinction. Simple approaches to consider the outcome of the new variant [8], [6] could be incorporated in our models, but ultimately this is a complex process [3] so a full description will require significant further development of models.

Data Availability

There is no data used in this manuscript. The results are reproducible only with the information presented in the manuscript.

Declaration of interests

We declare we have no competing interests.

A Mathematical proofs

A.1 Polarised vaccine immunity

Using the notation of the main text, define column vectors u(t) and v(t) as Embedded Image where xT denotes the transpose of a vector x. Consider an ODE system Embedded Image for a time-dependent matrix M, which possibly depends on v and v. Suppose initial conditions Embedded Image for some constant α. û (t) := α−1v(t) and u(t) obey the same first order differential equation (A2) and initial condition u(0) = û (0). Hence (by uniqueness of solutions), û (t) = u(t). Thus v(t) = αu(t).

Analytic results for the transient polarised model

The system (2)-(4) can be written in the form (A1)-(A3) with Embedded Image and α = cθS/(1 − c). Thus (SV (t), IV (t), RV (t)) = cθS(1 − c)−1(SU (t), IU (t), RU (t)). This relation (5) allows us to derive (6), which yields Embedded Image where the initial conditions (7) set the integration constant. The final size of the susceptible population, Embedded Image, is given implicitly by taking t → ∞ and setting 0 = limt→∞ IU (t): Embedded Image The second equality expresses Embedded Image in terms of the Lambert-W function [24] and Re. From Embedded Image we obtain (8) for the escape pressure Pa(c), which we study here. For simplicity, we set W ≡ W (−Re−R) and R ≡ Re. Embedded Image Embedded Image Embedded Image Embedded Image Embedded Image See, e.g., [24] for the derivative of the Lambert-W function used in (A7). We prove that there is either none or one root (c = cm) solving dPa/dc = 0 in Embedded Image. W ≥ −1, and hence (1 + W/R) > 0, because R > 1 for c < cm. Thus it suffices to consider the sign and monotonicity of the bracketed (right-most) term in (A10). First suppose (1 − θSθE) > 0, which means (1 − c(1 − θSθE)) > 0. Since W/(W + 1) < 0, dPa/dc < 0. So if θE < 1/θS, vaccination reduces the escape pressure regardless of the coverage c. Now consider θEθS > 1. R decreases with c and R > 1 for Embedded Image increases with R > 1, so z decreases with Embedded Image. The Lambert W function W (z) increases with its argument z ∈ (−1/e, 0), so it decreases with c. W/(1 + W) is an increasing function of W ∈ (0, − 1) and hence it is a negative, decreasing function of c. These imply Embedded Image where the first derivative in the RHS is positive and the second is negative. Hence the LHS is negative. Thus dPa/dc is a decreasing function of c, with at most one root, cm. The if and only if condition for cm > 0 is dPa/dc > 0 at c = 0. Evaluating (A10) at c = 0, the condition for cm > 0 becomes Embedded Image (A12), as (19), can be written in the form (escape boost) > g(R0)(transmission blocking) for a function g. Here g(R0) = −W0/(1 + W0); while in the endemic scenario, g(R0) = 1/(R0 − 1).

Analytic results the endemic models

The SIRS system (10)-(12) can be written in the form (A1)-(A3) with Embedded Image and Embedded Image. Thus, (5) holds. We write the system with natural dynamics (13)-(15) as Embedded Image, with Embedded Image and Embedded Image for α = cθS/(1 − c). Both u(t), û (t) := α−1v(t) solve the initial value problem Embedded Image. By uniqueness of solutions, u(t) = û (t), and hence (5) still holds.

A.2 Analytical results for leaky vaccine immunity

We modify the SIR model of Section 2.2 to have “leaky” immunity, instead of polarised [16]: Embedded Image Embedded Image Embedded Image For c = 1 or c = 0, (A13)-(A15) become a standard SIR model: Embedded Image, İ = R0SI − I, S(0) = 1 ≫ I(0) > 0 if c = 0, and the same but with R0 → R0θSθI for c = 1. We assume R0θSθI, R0 > 1 so that the outbreak grows in both situations. The final sizes are Embedded Image respectively, where W is the Lambert-W function [24]. From (A16) and (18) we find that the relative escape pressure in a fully-vaccinated population under the “leaky” immunity assumption is Embedded Image, proportional to the relative escape pressure under polarised immunity. Figures S1a, S1c are hence identical, except for the vertical variables, θE and θSθE.

For c ∈ (0, 1), from (A13), Embedded Image and so Embedded Image, which deviates from (5). However, we can still study the system through SU (t) and λ(t) = IS + θIIV : Embedded Image Using the chain rule and the initial conditions (A15), Embedded Image Embedded Image Setting limt→∞ λ(t) = 0, (A19) defines Embedded Image, the final size of the unvaccinated susceptible compartment: Embedded Image Embedded Image and Embedded Image so, for 0 < c < 1, Embedded Image and where Embedded Imageis the unique solution in (0, 1 −c) of (A19) for Re > 1. For Re ≤ 1, we set Pa′ = 0. Figures S1b, S1d are the equivalent of Figure 1b for the “leaky” and polarised transient models. The effect of θE is qualitatively the same in all models, regardless of vaccination coverage.

S Supplementary Figures

Figure S1:
  • Download figure
  • Open in new tab
Figure S1:

As Figure 1 but for the transient scenario. The qualitative behaviour is the same as in the endemic scenario. Top row is with polarised immunity, bottom row is for leaky immunity. The escape pressure is larger with leaky immunity instead of polarised immunity (as seen in the different variables in the vertical axis of (c) or the maximum values of Embedded Image attained in (d)).

Figure S2:
  • Download figure
  • Open in new tab
Figure S2:

As Figure 2, but for the transient scenario with polarised immunity. The qualitative behaviour is the same as in the endemic scenario. The same behaviour appears in the transient scenario with leaky immunity (plots not shown).

Figure S3:
  • Download figure
  • Open in new tab
Figure S3:

As Figure 2, but with a lower relative contribution to escape from vaccinated hosts: θE = 5 instead of θE = 10. Here vaccination that fully blocks infection (θS = 0) or onward transmission (θI = 0) reduces the escape pressure at any vaccination coverage (Embedded Image for c > 0). In other words, here Embedded Image. However, the escape pressure is still more sensitive to θS than θI. The same behaviour appears in the transient scenario with leaky or polarised immunity (plots not shown).

Figure S4:
  • Download figure
  • Open in new tab
Figure S4:

Relative escape pressure Embedded Image as a function of the vaccine efficacies θS and θI for a fixed vaccination coverage c = 0.1. (a) is for the transient scenario and (b) is for the endemic scenario: the qualitative results are the same. As expected, reducing θS or θI decreases the escape pressure, because this corresponds to more effective vaccines. However, the contour lines that gives constant escape pressures are roughly vertical, meaning that the escape pressure decreases is much more sensitive to θS than θI. As in Figures 2, S2, R0 = 1.4 and θE = 10. The same behaviour appears in the transient scenario with leaky immunity (plots not shown).

Figure S5:
  • Download figure
  • Open in new tab
Figure S5:

Embedded Image (the value of the relative contribution to escape from the vaccinated above which intermediate coverages maximise the escape pressure) in the endemic scenario, as given by (19). We only plot values of the susceptibility VE θS above 0.4, because Embedded Image quickly grows without bounds as θS → 0 (the vaccines become better at preventing infection). In other words, Embedded Image is more sensitive to θS than θI, as Embedded Image (see, e.g., Figure S4). R0 = 1.4.

Figure S6:
  • Download figure
  • Open in new tab
Figure S6:

As Figures 1b, S1b, but with different R0 such that vaccination alone cannot achieve herd-immunity Embedded Image. (a), (b): R0 = 2.8. The escape pressure is non-zero even in a fully vaccinated population (c = 1), because there is still transmission. Nevertheless, the vaccination coverage that maximises the escape pressure is always less than 1, so the escape pressure does not peak at a fully vaccinated population regardless of how much cases in vaccinated individuals contribute to the escape pressure (cm < 1). Embedded Image is the vertical asymptote of the white curve, the limit of cm as θE → ∞. (c), (d): R0 = 9. For large θE, the escape pressure increases monotonically with the vaccination coverage c and is largest at a fully-vaccinated population (c = 1). As with the other plots of this paper, the qualitative behaviour of the transient (left columns) and endemic (right column) scenarios is the same. We do not show plots for the transient scenario with leaky immunity, but the qualitative behaviour is the same.

Acknowledgements

MAG is supported by the Gates Cambridge Trust (grant OPP1144 from the Bill & Melinda Gates Foundation).

Footnotes

  • ↵† jrg20{at}cam.ac.uk

References

  1. [1].↵
    Telenti A, Arvin A, Corey L, Corti D, Diamond MS, García-Sastre A, et al. After the pandemic: perspectives on the future trajectory of COVID-19. Nature. 2021.
  2. [2].↵
    Saad-Roy CM, Wagner CE, Baker RE, Morris SE, Farrar J, Graham AL, et al. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years. Science. 2020.
  3. [3].↵
    Morris DH, Petrova VN, Rossine FW, Parker E, Grenfell BT, Neher RA, et al. Asynchrony between virus diversity and antibody selection limits influenza virus evolution. eLife. 2020.
  4. [4].↵
    Gog JR, Hill EM, Danon L, Thompson RN. Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model. Royal Soc Open Sci. 2021.
  5. [5].↵
    Saad-Roy CM, Morris SE, Metcalf CJE, Mina MJ, Baker RE, Farrar J, et al. Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes. Science. 2021.
  6. [6].↵
    McLean AR. Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework. Proc Royal Soc B. 1995.
  7. [7].↵
    Gandon S, Day T. The evolutionary epidemiology of vaccination. J R Soc Interface. 2007.
  8. [8].↵
    Rella SA, Kulikova YA, Dermitzakis ET, Kondrashov FA. Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains. Sci Rep. 2021.
  9. [9].↵
    Yewdell JW. Antigenic drift: Understanding COVID-19. Immunity. 2021.
  10. [10].↵
    Parums DV. Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2. Med Sci Monit. 2021.
  11. [11].↵
    Alizon S, Sofonea MT. SARS-CoV-2 virulence evolution: Avirulence theory, immunity and trade-offs. J Evol Biol. 2021.
  12. [12].↵
    Hu J, Peng P, Cao X, Wu K, Chen J, Wang K, et al. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell Mol Immunol. 2022.
  13. [13].↵
    Gandon S, Mackinnon MJ, Nee S, Read AF. Imperfect vaccines and the evolution of pathogen virulence. Nature. 2001.
  14. [14].↵
    Kennedy DA, Read AF. Monitor for COVID-19 vaccine resistance evolution during clinical trials. PLOS Biol. 2020.
  15. [15].↵
    Wen FT, Malani A, Cobey S. The Potential Beneficial Effects of Vaccination on Antigenically Evolving Pathogens. Am Nat. 2022.
  16. [16].↵
    Gog JR, Grenfell BT. Dynamics and selection of many-strain pathogens. Proc Natl Acad Sci USA. 2002.
  17. [17].↵
    Boni MF, Gog JR, Andreasen V, Feldman MW. Epidemic dynamics and antigenic evolution in a single season of influenza A. Proc Royal Soc B. 2006.
  18. [18].↵
    Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, et al. Hemagglutinin receptor binding avidity drives influenza a virus antigenic drift. Science. 2009 10;326(5953):734–6.
    OpenUrlAbstract/FREE Full Text
  19. [19].↵
    Kelvin AA, Falzarano D. The influenza universe in an mRNA vaccine. Science. 2022 11;378(6622):827–8.
    OpenUrl
  20. [20].↵
    Arevalo CP, Bolton MJ, Le Sage V, Ye N, Furey C, Muramatsu H, et al. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes. Science. 2022 11;378(6622):899–904.
    OpenUrl
  21. [21].↵
    Kissler SM, Fauver JR, Mack C, Tai CG, Breban MI, Watkins AE, et al. Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons. N Engl J Med. 2021.
  22. [22].↵
    Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, Mumford JA, et al. Unifying the Epidemiological and Evolutionary Dynamics of Pathogens. Science. 2004.
  23. [23].↵
    Garcia-Beltran WF, Lam EC, St Denis K, Nitido AD, Garcia ZH, Hauser BM, et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021.
  24. [24].↵
    Lehtonen J. The Lambert W function in ecological and evolutionary models. Methods Ecol Evol. 2016.
  25. [25].↵
    Ferguson NM, Andreasen V. The Influence of Different Forms of Cross-Protective Immunity on the Population Dynamics of Antigenically Diverse Pathogens. In: Mathematical Approaches for Emerging and Reemerging Infectious Diseases: Models, Methods, and Theory. The IMA Volumes in Mathematics and its Applications.. vol. 126. Springer, New York, NY; 2002. p. 157–69.
    OpenUrl
  26. [26].↵
    Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med. 2020.
Back to top
PreviousNext
Posted November 29, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The importance of vaccinated individuals to population-level evolution of pathogens
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The importance of vaccinated individuals to population-level evolution of pathogens
Maria A. Gutierrez, Julia R. Gog
medRxiv 2022.11.29.22282822; doi: https://doi.org/10.1101/2022.11.29.22282822
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The importance of vaccinated individuals to population-level evolution of pathogens
Maria A. Gutierrez, Julia R. Gog
medRxiv 2022.11.29.22282822; doi: https://doi.org/10.1101/2022.11.29.22282822

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3289)
  • Dentistry and Oral Medicine (364)
  • Dermatology (277)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1170)
  • Epidemiology (13365)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5152)
  • Geriatric Medicine (482)
  • Health Economics (782)
  • Health Informatics (3264)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (429)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14624)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (127)
  • Nephrology (522)
  • Neurology (4922)
  • Nursing (262)
  • Nutrition (729)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2520)
  • Ophthalmology (723)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1301)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (556)
  • Psychiatry and Clinical Psychology (4206)
  • Public and Global Health (7501)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1012)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)